In type 2 diabetes, liraglutide reduced CV events at 5 y vs. glargine, glimepiride, or sitagliptin. Brown K, Donato AA. Ann Intern Med 2023 Jan 3. doi: 10.7326/J22-0105.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Brown K, Donato AA. In type 2 diabetes, liraglutide reduced CV events at 5 y vs. glargine, glimepiride, or sitagliptin. Ann Intern Med 2023 Jan 3. doi: 10.7326/J22-0105.
PMID: 36592466